|
C11ORF57 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.899200E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.00279999987785E-07 |
| Normal-vs-Stage2 |
3.377400E-01 |
| Normal-vs-Stage3 |
6.620600E-01 |
| Normal-vs-Stage4 |
4.250800E-01 |
| Stage1-vs-Stage2 |
6.242200E-02 |
| Stage1-vs-Stage3 |
3.7897000000342E-06 |
| Stage1-vs-Stage4 |
1.92106999999941E-05 |
| Stage2-vs-Stage3 |
2.023800E-01 |
| Stage2-vs-Stage4 |
1.650570E-01 |
| Stage3-vs-Stage4 |
7.218600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.137900E-03 |
| Normal-vs-AfricanAmerican |
2.869800E-01 |
| Normal-vs-Asian |
3.020600E-01 |
| Caucasian-vs-AfricanAmerican |
5.755400E-03 |
| Caucasian-vs-Asian |
9.410400E-01 |
| AfricanAmerican-vs-Asian |
2.851800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.156100E-02 |
| Normal-vs-Female |
6.195300E-03 |
| Male-vs-Female |
3.624200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.131400E-01 |
| Normal-vs-Age(41-60Yrs) |
2.058100E-03 |
| Normal-vs-Age(61-80Yrs) |
5.396100E-02 |
| Normal-vs-Age(81-100Yrs) |
5.007600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.751600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.991200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.685000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.817590E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.999900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.308210E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.95589999999868E-05 |
| Normal-vs-Grade 2 |
5.49140000138948E-08 |
| Normal-vs-Grade 3 |
4.229000E-01 |
| Normal-vs-Grade 4 |
4.882100E-03 |
| Grade 1-vs-Grade 2 |
4.746600E-01 |
| Grade 1-vs-Grade 3 |
1.026030E-02 |
| Grade 1-vs-Grade 4 |
6.06899999999744E-05 |
| Grade 2-vs-Grade 3 |
1.54949999997545E-06 |
| Grade 2-vs-Grade 4 |
2.27279972619954E-10 |
| Grade 3-vs-Grade 4 |
7.028200E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.82620585320592E-12 |
| Normal-vs-ccB subtype |
1.865620E-01 |
| ccA subtype-vs-ccB subtype |
1.11022302462516E-16 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.085900E-02 |
| Normal-vs-N1 |
1.387410E-01 |
| N0-vs-N1 |
3.417900E-02 |
|
|
